Search Within

Gary Schwartz

  1. "Michael Postow"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (2)
Groups
  1. Department of Medicine (7)
  2. Melanoma Disease Management Team (7)
  3. Melanoma and Immunotherapeutics Service (7)
  4. Solid Tumor Oncology Division (7)
  5. GSK Faculty (6)
  6. Hematologic Malignancies, Division of (6)

More Groups

People
  1. Michael Postow (7)
  2. Jedd Wolchok (6)
  3. Margaret Callahan (6)
  4. Richard Carvajal (6)
  5. Mark Dickson (5)
  6. Paul Chapman (5)

More People

Years
  1. 2014 (2)
  2. 2013 (2)
  3. 2012 (3)
Publications
  1. Journal of Clinical Oncology (4)
  2. Cancer (1)
  3. Pigment Cell & Melanoma Research (1)
  4. The Oncologist (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. Wiley Blackwell (2)
  3. Oxford University Press (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1b/2 study of LEE011 in combination with binimetinib (MEK162) in patients with NRAS-mutant melanoma: Early encouraging clinical activity
    Meeting Abstract

    Sosman, J. A.; Kittaneh, M.; Lolkema, Mpjk; Postow, M. A.; Schwartz, G.; Franklin, C.; Matano, A.; Bhansali, S.; Parasuraman, S.; Kim, K.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • The Memorial Sloan Kettering Cancer Center (MSKCC) experience of systemic therapy in mucosal melanoma
    Meeting Abstract

    Bitas, C.; Shoushtari, A. N.; Bluth, M. J.; Bhuchar, G.; Hester, R. H.; Romero, J.; Fitzpatrick, L.; Lefkowitz, R. A.; Panageas, K.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinical activity of ipilimumab for metastatic uveal melanoma: A retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience
    Journal Article

    Luke, J. J.; Callahan, M. K.; Postow, M. A.; Romano, E.; Ramaiya, N.; Bluth, M.; Giobbie-Hurder, A.; Lawrence, D. P.; Ibrahim, N.; Ott, P. A.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • Ipilimumab for patients with advanced mucosal melanoma
    Journal Article

    Postow, M. A.; Luke, J. J.; Bluth, M. J.; Ramaiya, N.; Panageas, K. S.; Lawrence, D. P.; Ibrahim, N.; Flaherty, K. T.; Sullivan, R. J.; Ott, P. A.; more...
    The Oncologist (2013)

    Fulltext@MSK | Save
  • Evaluation of the absolute lymphocyte count as a biomarker for melanoma patients treated with the commercially available dose of ipilimumab (3mg/kg)
    Meeting Abstract

    Postow, M. A.; Yuan, J.; Panageas, K.; Bogatch, K.; Callahan, M.; Cheng, M.; Schroeder, S. E. A.; Kendle, R. F.; Harding, J. J.; Dickson, M. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Ipilimumab in the treatment of uveal melanoma: The Memorial Sloan-Kettering Cancer Center experience
    Meeting Abstract

    Khan, S. A.; Callahan, M.; Postow, M. A.; Chapman, P. B.; Schwartz, G. K.; Dickson, M. A.; D'Angelo, S. P.; Luke, J. J.; Bluth, M. J.; Roman, R. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Infliximab (IFX) for ipilimumab (IPI)-induced colitis in melanoma patients (pts)
    Meeting Abstract

    Harding, J. J.; Callahan, M.; Postow, M.; Rocco, K.; D'Angelo, S.; Dickson, M.; Carvajal, R.; Schwartz, G. K.; Wolchok, J.; Chapman, P.
    Pigment Cell & Melanoma Research (2012)

    Fulltext@MSK | Save